Lakefront Biotherapeutics NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LKFT | BHVN | SLS | NKTR | LEGN | IOVA | |
|---|---|---|---|---|---|---|
| Market cap | 1.94B | 1.78B | 2.41B | 1.36B | 3.46B | 6.60B |
| P/E (TTM) | 2.8 | — | — | — | — | — |
| Forward P/E | -24.9 | -6.3 | -119.3 | -3.9 | 17.0 | -67.9 |
| Price/book | 10.5 | 145.8 | 17.5 | 1.5 | 2.8 | 9.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −12.35% | −29.11% | +481.95% | −28.28% | −43.32% | +583.18% |
| Today | −0.54% | −2.24% | +2.40% | −3.23% | −4.40% | −0.41% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LKFT news ›Lakefront Biotherapeutics Discloses Bank of America Stake Cut Below 10% Threshold
Lakefront Biotherapeutics ( (LKFT) ) has issued an announcement. On October 8, 2026, Lakefront Biotherapeutics reported that it had received a transparency notification under Belgian disclosure rules from Bank of America Corporation. The…
Demetra Holdings buys back 5,057 of its own shares
Demetra Holdings Plc bought back 5,057 of its own shares on October 9, 2026, at an average price of €1.35 per share, the company announced on Monday. The purchases were carried out through the Cyprus Investment & Securities Corporation Ltd…
Lakefront Biotherapeutics NV: News in other languages | LKFT | BE0003818359
Lakefront Biotherapeutics NV: News, information and stories for Lakefront Biotherapeutics NV | Euronext Amsterdam: LKFT | Euronext Amsterdam Other languages Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news…
Lakefront Biotherapeutics NV : Insider Transactions
Follow insider transactions on Lakefront Biotherapeutics NV in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Lakefront Biotherapeutics NV Biotechnology & Medical…
Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation
Published on 08/24/2026 at 04:43 pm EDT - Modified on 08/24/2026 at 04:44 pm EDT A Lakefront Biotherapeutics treatment for the autoimmune disorder pemphigus received orphan drug designation from the Food and Drug Administration. The…
Lakefront Biotherapeutics NV: Latest Headlines - Euronext Amsterdam Stock Exchange
Find the latest highlights on Lakefront Biotherapeutics NV at the Euronext Amsterdam stock exchange. Highlights Lakefront Biotherapeutics NV Biotechnology & Medical Research All financial news and data tailored to specific country editions
Lakefront Biotherapeutics NV Announces Resignation of Paulo Fontoura as Director
Lakefront Biotherapeutics NV announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo Fontoura had tendered his... Published on 07/13/2026 at 04:50 pm EDT…
Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US
Lakefront Biotherapeutics' and Gilead Sciences' gamgertamig received orphan drug status from the US Food and Drug Administration for the additional treatment of a skin disorder called... Lakefront Biotherapeutics, Gilead Secure Another…
Owners buy their stocks
Last month, Mitsubishi Corp finalized a deal for the acquisition of a 10 percent stake in AC through a partial tender offer. In this case, the buyer is not a majority owner but a business partner of the Ayala group. The transaction value…
Total current assets of Lakefront Biotherapeutics – XETR:GXE
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com19
-
tradingview.com15
-
stocktitan.net11
-
kalkinemedia.com4
-
scanx.trade3
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 73 articles, not a forecast.